Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Q4 2022 Earnings Call Transcript
Operator: Greetings and welcome to the Processa Pharmaceuticals Year-End 2022 Earnings Call and Corporate Update. As a reminder, this call is being recorded.
Processa Pharmaceuticals Inc. (PCSA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.45 | 21,000 | 79,387 | 2024-02-07 | Filing | ||
| $2.53 | 20,000 | 58,387 | 2024-02-06 | Filing | ||
| $2.40 | 1,500 | 27,478 | 2024-02-01 | Filing | ||
| $2.37 | 2,500 | 25,978 | 2024-01-31 | Filing | ||
| $2.70 | 10,000 | 20,000 | 2024-01-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.30 | 1,854 | Director | 532,563 | 2022-01-27 | Filing | |
| $4.71 | 4,200 | Director | 534,417 | 2021-12-06 | Filing | |
| $4.84 | 5,500 | Director | 538,617 | 2021-12-03 | Filing | |
| $11.56 | 20,929 | Large Shareholder | 1,096,071 | 2021-02-22 | Filing | |
| $11.20 | 3,000 | Large Shareholder | 1,117,000 | 2021-02-19 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 11,732.65 | $78,515 | 0% | |
| 2. | 6,101.65 | $40,832 | 0% | |
| 3. | 4,001.15 | $26,808 | 0% | |
| 4. | 3,843.25 | $25,719 | 0% | |
| 5. | 2,315.3 | $15,000 | 0% |
News See All
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Q3 2022 Earnings Call Transcript
Operator: Greetings, and welcome to Processa Pharmaceuticals third-quarter 2022 earnings call and corporate update. At this time, all participants are in a listen-only mode.
Is Processa Pharmaceuticals, Inc. (PCSA) A Good Stock To Buy?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Billionaire Hedge Funds
